Health Care Roundup: Market Talk
Find insight on Novartis and Genmab in the latest Market Talks covering Health Care.
We haven't written up this one. WSJ Markets has the full story — the link below goes straight to it.
More in Health & Medicine
Endocrinologist Unpacks Why People Living with Diabetes in India Delay Treatment
Over 100 million people in India are estimated to be living with diabetes, and many with the most common form, type 2 diabetes, delay insulin therapy by seven to nine years, according to studies.
WHO launches clinical trial for Bundibugyo Ebola vaccines in Congo
The World Health Organization has begun a clinical trial for Bundibugyo Ebola vaccines in Congo, with four people vaccinated in the first phase.
Menopausal Hormone Therapy May Boost GLP-1 Weight Loss
(MedPage Today) -- Menopausal women taking hormone therapy in addition to a GLP-1 medication may see greater and sustained weight loss, a retrospective cohort study suggested.
Nurse killed and health worker injured in DR Congo Ebola attack
By Nana Karikari, Senior Global Affairs Correspondent A deadly attack in the northeastern Democratic Republic of Congo has left a nurse dead and another health responder severely injured.
Tobacco use disparities persist despite declining consumption in India, US: Study
The analysis found that while tobacco products differed between the two countries, social and geographical inequalities remained common challenges
SC questions Centre over medicine price markups, says hospitals cannot survive through 'dacoity'
The Supreme Court on Tuesday questioned the Centre over the massive disparity between the maximum retail price (MRP) of medicines and their price to retailers, asking why the system appeared to favour…